Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice
暂无分享,去创建一个
[1] H. Kim,et al. Platelet-Derived Growth Factor D Is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma Cells , 2005, Molecular and Cellular Biology.
[2] Y. Zhen,et al. PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury. , 2005, Biochemical and biophysical research communications.
[3] K. Alitalo,et al. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. , 2004, Blood.
[4] C. Fieber,et al. Tissue plasminogen activator is a potent activator of PDGF‐CC , 2004, The EMBO journal.
[5] D. Dichek,et al. Overexpression of Urokinase by Macrophages or Deficiency of Plasminogen Activator Inhibitor Type 1 Causes Cardiac Fibrosis in Mice , 2004, Circulation research.
[6] C. Betsholtz,et al. A specific requirement for PDGF-C in palate formation and PDGFR-α signaling , 2004, Nature Genetics.
[7] E. Raines. PDGF and cardiovascular disease. , 2004, Cytokine & growth factor reviews.
[8] C. Betsholtz. Insight into the physiological functions of PDGF through genetic studies in mice. , 2004, Cytokine & growth factor reviews.
[9] J. Bonner,et al. Regulation of PDGF and its receptors in fibrotic diseases. , 2004, Cytokine & growth factor reviews.
[10] J. Hoover-Plow,et al. The functions of plasminogen in cardiovascular disease. , 2004, Trends in cardiovascular medicine.
[11] D. Dichek,et al. Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death , 2004, Circulation.
[12] C. Alpers,et al. J Am Soc Nephrol 15: 286–298, 2004 Exogenous PDGF-D Is a Potent Mesangial Cell Mitogen and Causes a , 2022 .
[13] T. Sjöblom,et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. , 2003, The American journal of pathology.
[14] A. Cho,et al. Matrix Metalloproteinase-9 Is Necessary for the Regulation of Smooth Muscle Cell Replication and Migration After Arterial Injury , 2002, Circulation research.
[15] A. Hamsten,et al. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. , 2002, The American journal of pathology.
[16] M. Moore,et al. Platelet-derived Growth Factor C (PDGF-C), a Novel Growth Factor That Binds to PDGF α and β Receptor* , 2001, The Journal of Biological Chemistry.
[17] K. Alitalo,et al. Chromosomal Location, Exon Structure, and Vascular Expression Patterns of the Human PDGFC and PDGFD Genes , 2001, Circulation.
[18] C. Heldin,et al. PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor , 2001, Nature Cell Biology.
[19] J. Rothberg,et al. PDGF-D, a new protease-activated growth factor , 2001, Nature Cell Biology.
[20] R. Fandrich,et al. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. , 2001, American journal of physiology. Heart and circulatory physiology.
[21] N. Samani,et al. Expression of the plasminogen activator system in the human vascular wall. , 2000, Atherosclerosis.
[22] C. Heldin,et al. PDGF-C is a new protease-activated ligand for the PDGF α-receptor , 2000, Nature Cell Biology.
[23] L. Field,et al. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. , 2000, Circulation research.
[24] L. Powell-Braxton,et al. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[25] R. Schwartz,et al. Local insulin‐like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] C. Betsholtz,et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.
[27] W. Cavenee,et al. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. , 1999, Cancer research.
[28] C. Heldin,et al. Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.
[29] A. Demetris,et al. Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. , 1997, Journal of cardiac failure.
[30] J. Robbins,et al. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.
[31] Kenneth W. Watson,et al. A Decade of Progress , 1972, Journal of The Royal Naval Medical Service.
[32] P. Carmeliet,et al. Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. , 2005, The American journal of pathology.
[33] I. Komuro,et al. Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy Roles of Cardiac Transcription Factors in Cardiac Hypertrophy Ras, Akt, and Mechanotransduction in the Cardiac Myocyte G Protein–Coupled Signaling and Gene Expression Genetic Models and Mechanisms of Transcription in Car , 2003 .
[34] Dian Feng,et al. Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.